Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT03549351
Eligibility Criteria:
Inclusion Criteria:
* Acute myeloid leukemia according to the WHO classification
* Informed consent in place for a randomized study of the Study Alliance Leukemia (SAL) including the Heidelberg Leukemia Network (HeLeNe) covering assessment of MRD by MPFC in the reference laboratories in Heidelberg and Dresden.
Exclusion Criteria:
* No signed informed consent compliant with the requirements of PERDAM
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03549351
Study Brief:
Protocol Section:
NCT03549351